Among patients with documented stable coronary artery disease and in whom no revascularization was performed, we compared the respective values of angiographic diameter stenosis (DS) and fractional flow reserve (FFR) in predicting natural history.
F
ractional flow reserve (FFR) [1] [2] [3] [4] [5] has become the standard of reference for the invasive evaluation of coronary stenosis. [1] [2] [3] [4] 6 Patients with an FFR value >0.80 do not benefit from mechanical revascularization, whereas patients with an FFR ≤0.80 do benefit from revascularization. [7] [8] [9] FFR now has a class IA recommendation in the latest European Guidelines to guide myocardial revascularization in the absence of a conclusive noninvasive diagnostic workup. 10 Nevertheless, interventional cardiologists still prefer angiography for guiding decision making about revascularization, even in the absence of any budget and logistic constraints. 11 The angiographic thresholds of 50% or 70% diameter stenosis (DS) are still used to define obstructive coronary artery disease to risk stratify patients, 12 justify revascularization, serve as an end point in studies on revascularization strategies, 13, 14 and validate other approaches. 15, 16 Accordingly, we investigated the spontaneous, vesseloriented clinical outcome of patients from the FAME 2 trial (Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2) in whom no revascularization was performed but in whom both the angiographic (DS) and functional (FFR) severity was known. 8 The aim of the study was to compare the accuracy of both approaches in predicting the natural history of coronary artery disease.
METHODS
Anonymized patient-level data will be made available by the corresponding author for reasonable requests. Consent was not obtained for data sharing, but the presented data are anonymized and risk of identification is minimal.
Patients
The details of the FAME 2 trial have been previously reported. 8 In short, the FAME 2 trial randomized consecutive patients with stable angina and in whom 1-, 2-, or 3-vessel percutaneous revascularization was based on the visual estimate of the angiogram. FFR was measured in all stenoses that were considered potential targets for revascularization. If ≥1 lesion had an FFR ≤0.80, the patient was randomized to percutaneous coronary intervention (PCI) with second-generation drug-eluting stent (DES) or medical therapy. When no stenosis had an FFR ≤0.80, patients were enrolled in a registry and received the best medical therapy. A random sample of 50% of the registry patients underwent the same follow-up as the patients in the randomized trial. In the present analysis, we focused on patients who were treated only with the best available medical therapy alone and who had 2 years of clinical follow-up, namely, patients randomized to best available medical therapy (n=441) plus patients enrolled in the registry who underwent clinical followup (n=166). All patients provided written informed consent. The trial was approved by the institutional review board at the 23 participating centers in Europe and North America.
FFR was measured in all the stenoses with the use of a pressure monitoring guide wire (PressureWire Certus or PressureWire Aeris, St Jude Medical). Hyperemia was obtained with adenosine intravenous or intracoronary according to the operator's preference.
Quantitative coronary angiography was performed in all stenosis using the Medis software (Leiden, the Netherlands). The operator was blinded to the FFR values and the patient's clinical outcome. Angiographic DS, minimal lumen diameter (mm), lesion length (mm), and the reference lumen diameter (mm) of the proximal and distal reference segments were measured. A cutoff value of 50% was used for DS and 1.4 for minimal lumen diameter.
The SYNTAX score (Synergy between PCI with TAXUS and Cardiac Surgery) 17 was calculated in all patients by 4 different investigators blinded to each other, unaware of the segment in which the FFR was measured. The mean values of the global SYNTAX score were taken for analysis.
Study End Points
The primary end point of the present analysis trial was the rate of major adverse cardiovascular events at 2 years, defined as the composite of cardiovascular death, target vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (both urgent and nonurgent). All outcomes were adjudicated by an independent clinical events committee whose members were unaware of the treatment assignments and of the FFR and angiographic details of the lesions. The present study specifically investigates the relationship between vessel-related events defined as vessel-oriented clinical end point (VOCE) and lesion hemodynamics (FFR) or angiographic parameters (diameter stenosis and minimal luminal diameter). All the events at follow-up were blindly reviewed and unequivocally assigned to the culprit vessel in the cases of MI and ischemia-driven target vessel revascularization. When the identification of the culprit vessel was not possible or feasible (ie, in the case of cardiovascular death, no coronary angiography performed, or non-ST-segment elevation MI in patients with multivessel disease), the end point was assigned to all the stenotic vessels of those patients. According to their respective FFR and %DS values, the lesions
Clinical Perspective
What Is New?
• The data were obtained in a unique population of patients in whom no mechanical revascularization was initially proposed whatever the severity of the stenoses.
• The results indicate, for the first time, that the spontaneous clinical evolution (natural history) of coronary stenoses is better predicted by physiological information than by angiography.
What Are the Clinical Implications? (Figure 1 ).
Statistical Analysis
All analyses were done on the lesion level using robust standard errors that accounted for the correlation of lesions within patients. 
RESULTS

Patients and Vessels
Out of the 607 patients, both FFR and angiographic assessment of DS by quantitative coronary angiography was obtained in 567 (93%) patients (799 stenoses).
Forty patients were excluded because of lack of angiographies or to impossibility to calculate the DS related to ≥1 of the following factors: inadequate filling of the vessel by contrast medium, overlap of side branches, guiding catheter not well visible, foreshortening of the stenotic segment, and chronic total occlusion. (10) 31 (14) 31 (20) 31 (27) 0.003 Cerebrovascular accident, % 11 (3) 11 (5) 11 (7) 11 (10) Table 1 shows the baseline clinical characteristics and the angiographic and hemodynamic details of the whole population and of the 4 subgroups populations. Overall, the 4 groups were comparable except for peripheral vascular disease (highest rate in NM group versus lowest rate in PC group), the history of a previous PCI (highest rate in NM group versus lowest rate in PC group), the intertertile repartition of the SYNTAX score, the diameter stenosis percentage (highest value in PC group versus lowest value in NC group), the minimal lumen diameter (highest value in NC group versus lowest value in PC group), the lesion length (highest value in PC group versus lowest value in NC group), the stenosis localizations, and the FFR distribution. A pairwise testing among the groups for the characteristics that had significant overall P values is available in Table I in the online-only Data Supplement.
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Patients and Lesion Characteristics
Clinical Correlates
Clinical 2-year follow-up was available for all patients. The total number of VOCE and their individual components are shown in Figure 3 . Overall, VOCEs occurred in 26% of cases. Figure 4 shows the time-to-event curves for VOCE and their respective components in the 4 groups of patients. The color code is the same as in Figure 1 . There was no significant difference in terms of lesion-related outcome between the NM (FFR >0.80; DS ≥50%) and the NC (FFR >0.80; DS <50%), although there was a trend (P=0.099). When the angiographic cutoff was set at 70% DS, the outcome results did not change ( Figure  IA and IB in the online-only Data Supplement). Figure 5 and Figures II, III , IV, and V in the online-only Data Supplement show the time-to-event curves for the individual components of VOCE and illustrate that the differences in VOCE are driven by the rate of revascularizations. ORIGINAL RESEARCH ARTICLE Figure 6 shows that the rate of VOCE over time is significantly larger when lesions have a DS ≥50% or when lesions have an FFR ≤0.80, but the difference between the event curves is markedly larger for FFR than for DS. Table 2 shows the univariable analysis of predictors of VOCE. The global SYNTAX score was not found to be a significant predictor for vessel-related outcome (Table 2) . Table 3 shows the multivariable analysis of predictors of VOCE after forward selection of predictors. Only FFR, DS, and silent ischemia were selected for the model. On average, FFR ≤0.80 was associated with a 4.16-fold increase in the hazard of VOCE and DS ≥50% with a 1.36-fold increase. After introduction of an interaction term, FFR ≤0.80 was associated with a 7.28-fold increase in the hazard of VOCE during the first 90 days and a 3.29-fold increase in the hazard of VOCE occurring >90 days. 
DISCUSSION
Summary of Findings
The present analysis describes the 2-year outcome of a unique patient population, namely, patients with angiographically and physiologically fully characterized coronary artery disease and in whom no revascularization was proposed initially. Events were adjudicated by an independent clinical event committee, unaware of the angiogram and the FFR values. DS and FFR were compared side by side to clinical outcome data. The data indicate that the FFR value predicts the natural history significantly better than DS, suggesting that "physiology trumps anatomy." 19 In addition, among the stenoses with mismatch between DS and FFR, >50% had a low FFR in the presence of an angiographically mild stenosis.
Rate and Reasons for Mismatch
In the present study, an ≈33% rate of mismatch between DS and FFR was found. This finding is similar to what we found in previous work by Toth et al 15 (36%) as well as Park et al 20 in nonleft main stenoses (39%) and left main stenoses (40%). This relatively high rate of apparent discordance (mismatch) between anatomy and physiology is actually not surprising because it relates to many differ- ent factors. First, there are a number of specific reasons, such as inaccuracy of border detection, foreshortening of the stenotic segment, superimposition of side branches, asymmetry of the stenotic segment, and inaccuracies of the pressure measurements. Second, like every metrics in medicine, cutoff values of both DS and FFR are surrounded by a grey zone. However, the most important reason for the disconnect between anatomy and physiology relates to the myocardial mass that depends on the stenosis and vasodilatory capacity of the vascular bed. The reference diameter partially accounts for the myocardial mass. This is the reason that the optimal cutoff value for DS decreases when the diameter of the vessel increases, typically in LM and proximal left anterior descending artery. 15, 20 Also in the present data, left anterior descending artery stenoses are underrepresented in the group of NM and overrepresented in the group with a PM. Stated another way, any stenosis in the left anterior descending artery is more likely to be hemodynamically significant than in other arteries, even when its angiographic appearance is only mild. In contrast, the angiogram does not provide any clue about the vasodilatory capabilities of the micro- 
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vasculature in the downstream territory. This is illustrated by the finding that for a similar degree of angiographic severity, FFR is higher in older patients and patients with diabetes mellitus. [20] [21] [22] Moreover, FFR takes into account the entire epicardial resistance between the guiding and the pressure sensor, whereas DS provides more focal information. It is likely that discrete morphological lesion characteristics not captured by the angiogram such as lesion eccentricity, surface roughness, and the presence of plaque rupture influence lesion hemodynamics.
20
Outcome According to Physiology Versus Anatomy
There is a general belief that stenosis severity on angiography is related to worse outcomes. Many previous studies reported only an elusive link between angiographic severity of the lesions and patient outcomes. 23, 24 The present data indicate that, indeed, lesion-related outcome is better when DS is low (Figure 6 ). In contrast, robust data support a strong negative relationship between outcome and noninvasive signs of reversible myocardial ischemia. 25 A meta-analysis by Johnson and al 26 indicates that the higher the FFR, the better the outcomes. Yet in many of these patients, revascularization was performed based on the FFR values, which inevitably influences the relationship between the index value of FFR and the natural history of the patients. Recent data by Barbato et al 27 confirmed this dose-response relationship between the actual value of FFR and clinical outcome. There are, however, little data comparing side by side the prognostic value of anatomic and functional data in the same patients. 28 In addition, in none of these studies were the patients followed during a long period of time without mechanical intervention and the events adjudicated by an independent event committee. The present study is unique by the fact that, regardless of the severity of the stenoses, the patients were not treated by revascularization, so that the outcome data of the present study can be regarded as the natural history of the stenoses in stable patients without interference of PCI or coronary artery bypass surgery on the fate of these lesions.
In the present study, FFR predicted outcome markedly better than DS. In addition, the present data show that when a lesion is angiographically mild but hemodynamically significant, the event rate is as high when both angiography and hemodynamics indicate a significant lesion. Conversely, in the case of angiographically significant stenoses but hemodynamic nonsignificant stenosis, the clinical outcome is as favorable as when both angiography and hemodynamics indicate nonsignificant stenoses. In other words, what determines lesions-related outcome is less its angiographic appearance than its hemodynamic significance.
The SYNTAX score was developed in patients with angiographic 3-vessel disease to characterize the complexity of the stenoses and the extent of the atherosclerotic burden. 17 The SYNTAX score has proven useful in clinical decision making between coronary artery bypass surgery and PCI in these patients with 3-vessel disease mainly because coronary artery bypass surgery is largely immune to the anatomic complexity of the disease, whereas the technical aspects of the PCI procedures are heavily influenced by these anatomic characteristics. 29 It might sound intuitively logical to find some relationship between the SYNTAX score and the natural history of the stenosis. This was not found in the present dataset. It is important to realize that the SYNTAX score has been developed for patients with 3-vessel disease, whereas in the FAME 2 trial, the majority of patients had 1-or 2-vessel disease. Accordingly, the global SYNTAX score was markedly lower in FAME 2 than in most studies focusing on patients with 3-vessel disease. In addition, the present analysis focused on the lesionlevel outcome, whereas the SYNTAX score is a global estimate of atherosclerotic burden and complexity. Data derived from coronary CT angiography convincingly indicate that a high atherosclerotic burden is an independent predictor of hard events even in patients with angiographically nonobstructive coronary artery disease. 30 Therefore, the absence of relationship found between the SYNTAX score and the rate of VOCE seen in the present study should be interpreted with prudence. This total atherosclerotic burden is reflected by a lower FFR and is probably 1 of the mechanistic links to explain why FFR predicts events better than angiographic diameter stenosis.
A number of limitations should be taken into account. First, as in the original FAME 2 trial, neither the patients nor the physicians were blinded to the FFR values. 31 Second, this analysis was not prespecified in the initial protocol. Therefore, reliable quantitative coronary angiography analysis was not possible for technical reasons in a sizable proportion of stenoses (23%). It cannot be excluded that this has contributed to an enrichment of the trial population in mild to moderate stenoses. For the same reasons, the numbers in each subgroup of patients are relatively small. Even with these relatively Values indicate n (%), unless otherwise specified. CI indicates confidence interval.
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small subgroups, one can distinguish statistical trends toward differences in the rate of VOCE between the groups with an NC (FFR >0.8; DS<50%) and the group with an NM (FFR >0.80; DS>50%). Therefore, it cannot be excluded that with larger numbers the difference in outcome between the PM and PC groups as well as between the NM and NC groups would have become significant. However, this would not have changed the main conclusion of the study. Third, left main stenoses were not included in FAME 2. Therefore, the conclusions of the present analysis should be restricted to non-LM stenoses. Yet Park et al 20 showed that LM stenosesmore than non-LM stenosis-have a high proportion of PM precisely in these lesions that are underestimated by angiography and in which FFR is important because revascularization of these lesions have important prognostic implications. Fourth, the angiograms were not performed with the intention to perform quantitative coronary angiography or calculate the SYNTAX score. This might have contributed to a lower accuracy of these angiographic approaches.
CONCLUSION
From this side-by-side comparison of DS and FFR to lesion-related outcome, it appears that the main determinant of the natural history of a lesion is its hemodynamic significance rather than its angiographic appearance. DS is the cornerstone of the definition of CAD. 32 Because clinical outcome is the ultimate validation test for any new treatment or metrics, the present findings suggest that FFR should replace the 50% DS criteria for the definition of obstructive CAD. The multivariable model after forward selection of clinical and angiographic baseline characteristics is associated with Vessel-Oriented Clinical End Point reported in Table 2 , with significance for addition to the model set at P≤0. 15 . The proportional hazards test is based on Schoenfeld residuals positive for model 1 (P=0.013) and negative for model 2 (P=0.32) after the introduction of an interaction term between fractional flow reserve (≤0.80 versus >0.80) and time (≤90 days versus >90 days). CI indicates confidence interval.
